EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma

[1]  J. Pelletier,et al.  eIF4F suppression in breast cancer affects maintenance and progression , 2013, Oncogene.

[2]  Jun-hui Ge,et al.  Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma. , 2012, World Journal of Gastroenterology.

[3]  F. Khuri,et al.  Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer , 2012, Cancer biology & therapy.

[4]  Huiling Yang,et al.  Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma , 2010, BMC Cancer.

[5]  Long-Bang Chen,et al.  Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma. , 2009, Lung cancer.

[6]  C. Meschonat,et al.  Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome. , 2009, Surgery.

[7]  F. Abubakar,et al.  The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types , 2008, BMC public health.

[8]  R. Cencic,et al.  c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. , 2008, Cancer research.

[9]  N. Sonenberg.  eIF4E, the mRNA cap-binding protein: from basic discovery to translational research. , 2008, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  O. Larsson,et al.  Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. , 2007, Cancer research.

[11]  V. Polunovsky,et al.  The Cap-Dependent Translation Apparatus Integrates and Amplifies Cancer Pathways , 2006, RNA biology.

[12]  R. Lotan,et al.  Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin , 2005, Cancer biology & therapy.

[13]  G. Caldito,et al.  Overexpressed eIF4E Is Functionally Active in Surgical Margins of Head and Neck Cancer Patients via Activation of the Akt/Mammalian Target of Rapamycin Pathway , 2004, Clinical Cancer Research.

[14]  Amy R. Cameron,et al.  Characterization of mammalian eIF4E-family members. , 2004, European journal of biochemistry.

[15]  N. Sonenberg,et al.  Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. , 2004, Cancer cell.

[16]  King-Jen Chang,et al.  Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome , 2004, Journal of surgical oncology.

[17]  S. Fahrenkrug,et al.  Two Zebrafish eIF4E Family Members Are Differentially Expressed and Functionally Divergent* , 2004, Journal of Biological Chemistry.

[18]  D. Walsh,et al.  Increased levels of the translation initiation factor eIF4E in differentiating epithelial lung tumor cell lines. , 2003, Differentiation; research in biological diversity.

[19]  Jian-Min Yuan,et al.  Epidemiology of nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[20]  A. De Benedetti,et al.  Antisense RNA to eIF4E Suppresses Oncogenic Properties of a Head and Neck Squamous Cell Carcinoma Cell Line , 2000, The Laryngoscope.

[21]  T. Mok,et al.  Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. , 2000, Human pathology.

[22]  A. De Benedetti,et al.  Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[23]  A. De Benedetti,et al.  Overexpression of the proto‐oncogene/translation factor 4E in breast‐carcinoma cell lines , 1996, International journal of cancer.

[24]  N. Sonenberg,et al.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.